Long-term outcomes of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy (CCRT) vs CCRT alone for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy using propensity score matching method

References

• CoJMejiaMBDizonJMEvidence on effectiveness of intensity-modulated radiotherapy versus 2-dimensional radiotherapy in the treatment of nasopharyngeal carcinoma: meta-analysis and a systematic review of the literatureHead Neck201638suppl 1E2130E214225546181
   PubMedGoogle Scholar
• SuSFHanFZhaoCLong-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy aloneInt J Radiat Oncol Biol Phys201282132733321035959
   PubMed Web of Science ®Google Scholar
• TakiarVMaDGardenASDisease control and toxicity outcomes for T4 carcinoma of the nasopharynx treated with intensity-modulated radiotherapyHead Neck201638suppl 1E925E93325994561
   PubMedGoogle Scholar
• Al-SarrafMLeBlancMGiriPGChemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099J Clin Oncol1998164131013179552031
   PubMed Web of Science ®Google Scholar
• LeeAWTungSYNganRKFactors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 TrialsEur J Cancer201147565666621112774
   PubMed Web of Science ®Google Scholar
• LinJCJanJSHsuCYLiangWMJiangRSWangWYPhase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survivalJ Clin Oncol200321463163712586799
   PubMed Web of Science ®Google Scholar
• ChuaDTShamJSAuGKChoyDConcomitant chemoirradiation for stage III–IV nasopharyngeal carcinoma in Chinese patients: results of a matched cohort analysisInt J Radiat Oncol Biol Phys200253233434312023137
   PubMedGoogle Scholar
• ChenYLiuMZLiangSBPreliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of chinaInt J Radiat Oncol Biol Phys20087151356136418472356
   PubMed Web of Science ®Google Scholar
• ChenXLeiHLiangZLiLQuSZhuXIntensity-modulated radiotherapy controls nasopharyngeal carcinoma distant metastasis and improves survival of patientsSpringerplus201651145927652034
   PubMedGoogle Scholar
• SunYLiWFChenNYInduction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trialLancet Oncol201617111509152027686945
   PubMed Web of Science ®Google Scholar
• ChenYPGuoRLiuNEfficacy of the additional neoadjuvant chemotherapy to concurrent chemoradiotherapy for patients with locoregionally advanced nasopharyngeal carcinoma: a Bayesian Network Meta-analysis of Randomized Controlled TrialsJ Cancer20156988389226284140
   PubMed Web of Science ®Google Scholar
• HuiEPMaBBLeungSFRandomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinomaJ Clin Oncol200927224224919064973
   PubMed Web of Science ®Google Scholar
• LiangZZhuXLiLConcurrent chemoradiotherapy followed by adjuvant chemotherapy compared with concurrent chemoradiotherapy alone for the treatment of locally advanced nasopharyngeal carcinoma: a retrospective controlled studyCurr Oncol2014213e408e41724940100
   PubMedGoogle Scholar
• National Library of Medicine, National Institutes of HealthCommon terminology criteria for adverse events v4.0. [webpage on the Internet] Available from: http://evs.nci.nih.gov/ftp1/CTCAE/About.htmlAccessed May 22, 2017
   Google Scholar
• FountzilasGCiuleanuEBobosMInduction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluationAnn Oncol201223242743521525406
   PubMed Web of Science ®Google Scholar
• LiangZGZhuXDTanAHInduction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy with or without adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: meta-analysis of 1,096 patients from 11 randomized controlled trialsAsian Pac J Cancer Prev201314151552123534786
   PubMedGoogle Scholar
• WeeCWKeamBHeoDSSungMWWonTBWuHGLocoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapyRadiat Oncol J20153329810826157679
   PubMedGoogle Scholar
• LeeAWNganRKTungSYPreliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinomaCancer201512181328133825529384
   PubMed Web of Science ®Google Scholar
• SongJHWuHGKeamBSThe role of neoadjuvant chemotherapy in the treatment of nasopharyngeal carcinoma: a multi-institutional retrospective study (KROG 11-06) using propensity score matching analysisCancer Res Treat201648391792726727716
   PubMedGoogle Scholar
• YaoJJZhouGQZhangFNeoadjuvant and concurrent chemotherapy have varied impacts on the prognosis of patients with the ascending and descending types of nasopharyngeal carcinoma treated with intensity-modulated radiotherapyPLoS One20161110e016187827783618
   PubMedGoogle Scholar
• LanXWZouXBXiaoYRetrospective analysis of the survival benefit of induction chemotherapy in stage IVa-b nasopharyngeal carcinomaPLoS One2016118e016075827509025
   PubMedGoogle Scholar
• OuDBlanchardPEl KhouryCInduction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemo-radiotherapy or chemoradiotherapy alone in locally advanced non-endemic nasopharyngeal carcinomaOral Oncol20166211412127865364
   PubMed Web of Science ®Google Scholar
• TangCWuFWangRComparison between nedaplatin and cisplatin plus docetaxel combined with intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma: a multicenter randomized phase II clinical trialAm J Cancer Res2016692064207527725911
   PubMed Web of Science ®Google Scholar
• JinTQinWFJiangFInterim analysis of a prospective randomized non-inferiority trial of cisplatin and fluorouracil induction chemotherapy with or without docetaxel in nasopharyngeal carcinomaOncotarget Epub2016728
   Google Scholar
• LvXXiaWXKeLRComparison of the short-term efficacy between docetaxel plus carboplatin and 5-fluorouracil plus carboplatin in locoregionally advanced nasopharyngeal carcinomaOnco Targets Ther201695123513127574453
   PubMed Web of Science ®Google Scholar